Literature DB >> 7925616

Rat liver and kidney contain high densities of sigma 1 and sigma 2 receptors: characterization by ligand binding and photoaffinity labeling.

S B Hellewell1, A Bruce, G Feinstein, J Orringer, W Williams, W D Bowen.   

Abstract

Rat liver and kidney were investigated for the presence of sigma (sigma) receptor subtypes by radioligand binding with three highly selective sigma probes and by photoaffinity labeling using [3H]azido-di-o-tolylguanidine ([3H]azido-DTG). [3H](+)-Pentazocine, a highly selective sigma 1 probe, bound to sites in liver membranes with Kd = 7.5 nM and Bmax3 = 2929 fmol/mg protein. [3H](+)-Pentazocine binding sites in kidney had Kd = 23.3 nM and Bmax = 229 fmol/mg protein. [3H]1,3-Di-o-tolylguanidine ([3H]DTG) and [3H](+)-3-(3-hydroxyphenyl)-N-(1-propyl)piperidine ([3H](+)-3-PPP) label both sigma 1 and sigma 2 receptors. Parameters for [3H]DTG in the liver were Kd = 17.9 nM and Bmax = 11,895 fmol/mg protein. Similar parameters were observed for [3H](+)-3-PPP, Kd = 51.9 nM and Bmax = 11,070 fmol/mg protein. [3H]DTG bound to rat kidney with Kd = 45.8 nM and Bmax = 1190 fmol/mg protein. The observation that either [3H]DTG or [3H](+)-3-PPP and [3H](+)-3-PPP labeled a higher number of sites relative to [3H](+)-pentazocine suggested that liver and kidney contain both subtypes of sigma receptor. This was confirmed by competition studies vs. [3H](+)-pentazocine and [3H]DTG (in the presence of dextrallorphan to mask sigma 1 sites). In both tissues, [3H](+)-pentazocine labeled sites with high affinity for haloperidol and enantioselectivity for (+)-benzomorphans over (-)-benzomorphans. [3H]DTG + dextrallorphan labeled sites in both tissues which also had high affinity for haloperidol, but which had the characteristic sigma 2 property of low affinity for (+)-benzomorphans and enantioselectivity for (-)-benzomorphans over the corresponding (+)-isomer. Similar results were obtained with [3H](+)-3-PPP + dextrallorphan. Several novel aryl diamines, such as 1S,2R-cis-N-[2-(3,4-dichlorophenylethyl]-N-methyl-2- (1-pyrrolidinyl)cyclohexylamine (BD737) and N-[2-(3,4-dichlorophenyl)ethyl]-N-methyl-2-(1-pyrrolidinyl)ethylamine (BD1008), bound to both sites with high affinity. Photoaffinity labeling with 10 nM [3H]azido-DTG resulted in specific labeling of polypeptides of 25 kDa and 21.5 kDa. Dextrallorphan (100 nM or 500 nM) completely blocked labeling of the 25 kDa polypeptide, but had no effect on labeling of the lower molecular weight protein. (+)-10,11-Dihydro-5-methyl-5H-dibenzo[a,d]cyclohepten-5,10- imine((+)-MK-801) had no effect on labeling of either polypeptide. These data are consistent with the notion that the 25 kDa and 21.5 kDa proteins represent sigma 1 and sigma 2 receptors, respectively.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7925616     DOI: 10.1016/0922-4106(94)90115-5

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  116 in total

Review 1.  Sigma receptors: potential targets for a new class of antidepressant drug.

Authors:  James A Fishback; Matthew J Robson; Yan-Tong Xu; Rae R Matsumoto
Journal:  Pharmacol Ther       Date:  2010-05-11       Impact factor: 12.310

2.  σ1 receptors activate astrocytes via p38 MAPK phosphorylation leading to the development of mechanical allodynia in a mouse model of neuropathic pain.

Authors:  J Y Moon; D H Roh; S Y Yoon; S R Choi; S G Kwon; H S Choi; S Y Kang; H J Han; A J Beitz; S B Oh; J H Lee
Journal:  Br J Pharmacol       Date:  2014-11-24       Impact factor: 8.739

3.  The effect of the pyridyl nitrogen position in pyridylpiperazine sigma ligands.

Authors:  Lidiya Stavitskaya; Michael J Seminerio; Marilyn M Matthews-Tsourounis; Rae R Matsumoto; Andrew Coop
Journal:  Bioorg Med Chem Lett       Date:  2010-03-01       Impact factor: 2.823

4.  Nitrile analogs of meperidine as high affinity and selective sigma-1 receptor ligands.

Authors:  Susan L Mercer; Jamaluddin Shaikh; John R Traynor; Rae R Matsumoto; Andrew Coop
Journal:  Eur J Med Chem       Date:  2007-10-06       Impact factor: 6.514

5.  Divergent Cytotoxic and Metabolically Stimulative Functions of Sigma-2 Receptors: Structure-Activity Relationships of 6-Acetyl-3-(4-(4-(4-fluorophenyl)piperazin-1-yl)butyl)benzo[d]oxazol-2(3H)-one (SN79) Derivatives.

Authors:  Hilary E Nicholson; Walid F Alsharif; Anthony B Comeau; Christophe Mesangeau; Sebastiano Intagliata; Marco Mottinelli; Christopher R McCurdy; Wayne D Bowen
Journal:  J Pharmacol Exp Ther       Date:  2018-12-07       Impact factor: 4.030

6.  Juxtaposition of the steroid binding domain-like I and II regions constitutes a ligand binding site in the sigma-1 receptor.

Authors:  Arindam Pal; Uyen B Chu; Subramaniam Ramachandran; David Grawoig; Lian-Wang Guo; Abdol R Hajipour; Arnold E Ruoho
Journal:  J Biol Chem       Date:  2008-05-07       Impact factor: 5.157

7.  σ1-Receptor Agonism Protects against Renal Ischemia-Reperfusion Injury.

Authors:  Adam Hosszu; Zsuzsanna Antal; Lilla Lenart; Judit Hodrea; Sandor Koszegi; Dora B Balogh; Nora F Banki; Laszlo Wagner; Adam Denes; Peter Hamar; Peter Degrell; Adam Vannay; Attila J Szabo; Andrea Fekete
Journal:  J Am Soc Nephrol       Date:  2016-04-07       Impact factor: 10.121

8.  Interactions between 3,4-methylenedioxymethamphetamine and sigma1 receptors.

Authors:  Matthew K Brammer; Deborah L Gilmore; Rae R Matsumoto
Journal:  Eur J Pharmacol       Date:  2006-09-28       Impact factor: 4.432

9.  Antiproliferative and cytotoxic effects of some sigma2 agonists and sigma1 antagonists in tumour cell lines.

Authors:  Nicola Antonio Colabufo; Francesco Berardi; Marialessandra Contino; Mauro Niso; Carmen Abate; Roberto Perrone; Vincenzo Tortorella
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-07-31       Impact factor: 3.000

10.  Sigma-2 Receptors Play a Role in Cellular Metabolism: Stimulation of Glycolytic Hallmarks by CM764 in Human SK-N-SH Neuroblastoma.

Authors:  Hilary Nicholson; Christophe Mesangeau; Christopher R McCurdy; Wayne D Bowen
Journal:  J Pharmacol Exp Ther       Date:  2015-11-16       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.